Jing Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Newly Diagnosed

Epstein Barr Virus

Chronic Lymphocytic Leukemia

Top Venues

Expert opinion on pharmacotherapy

Blood and lymphatic cancer : targets and therapy

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Himil Mahadevia, Pedro Luiz Serrano Uson Junior, Jing Wang, Mitesh Borad, Hani Babiker
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Expert opinion on pharmacotherapy (2024)
Himil Mahadevia, Pedro Luiz Serrano Uson Junior, Jing Wang, Mitesh Borad, Hani Babiker
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Expert opinion on pharmacotherapy 25 (1) (2024)
Himil Mahadevia, Pedro Luiz Serrano Uson Junior, Jing Wang, Mitesh Borad, Hani Babiker
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Expert opinion on pharmacotherapy 25 (1) (2024)
Himil Mahadevia, Pedro Luiz Serrano Uson Junior, Jing Wang, Mitesh Borad, Hani Babiker
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Expert opinion on pharmacotherapy (2024)
Jing Wang, Firas Baidoun, Han W Tun, Muhamad Alhaj Moustafa
90 Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases. Blood and lymphatic cancer : targets and therapy 13 (2023)
Jing Wang, Christian Karime, Umair Majeed, Jason S Starr, Mitesh J Borad, Hani M Babiker
Targeting leukemia inhibitory factor in pancreatic adenocarcinoma. Expert opinion on investigational drugs (2023)
Jing Wang, Christian Karime, Umair Majeed, Jason S Starr, Mitesh J Borad, Hani M Babiker
Targeting leukemia inhibitory factor in pancreatic adenocarcinoma. Expert opinion on investigational drugs (2023)
Shenduo Li, Guilherme Sacchi de Camargo Correia, Jing Wang, Rami Manochakian, Yujie Zhao, Yanyan Lou
Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer. Cancers 15 (11) (2023)
Jing Wang, Christian Karime, Umair Majeed, Jason S Starr, Mitesh J Borad, Hani M Babiker
Targeting leukemia inhibitory factor in pancreatic adenocarcinoma. Expert opinion on investigational drugs (2023)
Jing Wang, Muhamad Alhaj Moustafa, Justin J Kuhlman, Karan Seegobin, Liuyan Jiang, Vivek Gupta, Han W Tun
Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy. Blood and lymphatic cancer : targets and therapy 12 (2022)
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, Jing Wang, Vivek Gupta, Han W Tun
Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma. Blood and lymphatic cancer : targets and therapy 12 (2022)